Harnessing Regenerative Gene Therapy for the Treatment of Cystic Fibrosis Lung Disease
Queen’s University Belfast
School of Pharmacy
Research Group:
Nanomedicine and biotherapeutics
Cystic fibrosis (CF) is a chronic airways disease caused by mutations in a cAMP-dependent chloride channel called the cystic fibrosis transmembrane conductance regulator (CFTR). In the lungs, defective ion channel activity and mucus obstruction results in chronic cycles of infection and inflammation, with tissue damage leading to progressive lung function decline and premature death. Read more
Supervisors: Prof L Martin, Prof C Taggart
Year round applications
PhD Research Project
Funded PhD Project (UK Students Only)